PharmaPatents Timely Insight on Emerging Legal Developments

Tag Archives: Review

Can Pharma Patents Benefit From The Peer-To-Patent Program?

Posted in Patent Office Practice

Last week the USPTO announced a new peer-to-patent pilot program that will include patent applications in the fields of biotechnology, bioinformatics, telecommunications, and speech recognition, in addition to the software and business methods applications that were included in the original pilot program. The USPTO touts the promise of a stronger patent and offers the incentive of prioritized examination, but applicants should understand the program details before volunteering their own applications for “peer review.”

Continue reading this entry